Abdominal Electrical Stimulation for Bowel Dysfunction in SCI
NCT ID: NCT06948175
Last Updated: 2025-09-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
NA
12 participants
INTERVENTIONAL
2025-07-14
2026-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Therefore, the investigators will do small study at the University of Alberta on 12 people who lived with SCI for more than 1 year, to find out the best way to apply the electrical stimulation, and to better understand how it works. The participants will use an electrical stimulator at home, to stimulate the skin with 4 sticky pads attached over the abdomen, without causing the muscles to contract. During a 2-month period, they will use the stimulator for 30 minutes before every bowel routine. The investigators will compare how long it takes to empty the bowel, stool consistency, and how long it takes for food to pass through the bowel, with and without using the electrical stimulator.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Abdominal Functional Electrical Stimulation to Improve Bowel Function in Spinal Cord Injury
NCT06345781
Stimulation for Bowel Emptying
NCT06078176
The Effect of NMES on Bowel Management in People with Chronic SCI
NCT04914975
Treatment of Fecal Incontinence and Constipation in Patients With Spinal Cord Injury
NCT00286520
Closed-loop Spinal Stimulation for Restoration of Upper Extremity Function After Spinal Cord Injury
NCT05267951
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
Phase 1 (duration 2 weeks): Participants apply their usual bowel routine for baseline observation.
Phase 2 (duration 4 weeks): In case that the initial assessment resulted in recommendations for improvement to the participant's usual bowel routine (See 2. Interventions), participants apply their optimized bowel routine in Phase 2 for 4 weeks. If no bowel routine adjustment was recommended, Phase 2 is omitted.
Phase 3 (duration 8 weeks): Participants apply abdominal TES for 30 minutes prior to every bowel routine. In case the bowel routine was optimized, they keep applying the optimized bowel routine.
Phase 4 (duration 4 weeks): Participants go back to their optimized bowel routine only, without using abdominal TES.
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Abdominal TES
Abdominal transcutaneuous electrical stimulation (TES)
Abdominal transcutaneous electrical stimulation (TES)
Low-intensity sensory abdominal transcutaneous electrical stimulation (TES)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Abdominal transcutaneous electrical stimulation (TES)
Low-intensity sensory abdominal transcutaneous electrical stimulation (TES)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. \>1 year post injury
3. Injury level C2 - S5 (NLI, neurological level of injury)
4. AIS A, B, C, D (American Spinal Injury Association Impairment Scale)
5. Feels defecation takes too long and wants to do something about it
6. Defecation takes \> 30 minutes
Exclusion Criteria
2. Inflammatory bowel disease
3. Pregnancy
4. Unable to give consent
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Praxis Spinal Cord Institute
OTHER
Glenrose Foundation
OTHER
University of Alberta
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Chester Ho, MD
Role: PRINCIPAL_INVESTIGATOR
University of Alberta, Faculty of Medicine and Dentistry
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Glenrose Rehabilitation Hospital
Edmonton, Alberta, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
G2025-13
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
Pro00150346
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.